FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2769601183> ?p ?o ?g. }

• W2769601183 endingPage "658" @default.
• W2769601183 startingPage "653" @default.
• W2769601183 abstract "Abstract Aim There is a variable cardiovascular risk reduction attributable to aspirin because of individual differences in the suppression of thromboxane A 2 and its downstream metabolite 11‐dehydro‐thromboxane B 2 (11dhTxB 2 ). The aim of this study is to evaluate the optimal cut point of urinary 11dhTxB 2 for the risk of mortality in aspirin‐treated coronary artery disease (CAD) patients. Methods and Results This was a prospective cohort study including stable CAD patients who visited the Baylor Heart and Vascular Hospital in Dallas or the Texas Heart Hospital Baylor Plano, TX between 2010 and 2013. The outcome of all‐cause mortality was ascertained from chart review and automated sources. The 449 patients included in this analysis had a mean age of 66.1 ± 10.1 years. 67 (14.9%) patients died within 5 years; 56 (87.5%) of the 64 patients with known cause of death suffered a cardiovascular related mortality. Baseline ln(urinary 11dhTxB 2 /creatinine) ranged between 5.8 and 11.1 (median = 7.2) with the higher concentrations among those who died (median: 7.6) than those who survived (median = 7.2, P < 0.001). Using baseline ln(11dhTxB 2 ) to predict all‐cause mortality, the area under the curve was 0.70 (95% CI: 0.64–0.76). The optimal cut point was found to be ln(7.38) = 1597.8 pg/mg, which had the following decision statistics: sensitivity = 0.67, specificity = 0.62, positive predictive value = 0.24, negative predictive value = 0.92, and accuracy = 0.63. Conclusion Our data indicate the optimal cut point for urine 11dhTxB2 is 1597.8 (pg/mg) for the risk prediction of mortality over five years in stable patients with CAD patients treated with aspirin." @default.
• W2769601183 created "2017-12-04" @default.
• W2769601183 creator A5001000588 @default.
• W2769601183 creator A5003077195 @default.
• W2769601183 creator A5007272877 @default.
• W2769601183 creator A5008382551 @default.
• W2769601183 creator A5022982945 @default.
• W2769601183 creator A5025868173 @default.
• W2769601183 creator A5028243601 @default.
• W2769601183 creator A5034295349 @default.
• W2769601183 creator A5040244597 @default.
• W2769601183 creator A5048484701 @default.
• W2769601183 creator A5060918182 @default.
• W2769601183 creator A5069704118 @default.
• W2769601183 date "2017-11-29" @default.
• W2769601183 modified "2023-09-26" @default.
• W2769601183 title "Prognostic value of urinary 11-dehydro-thromboxane B₂ for mortality: A cohort study of stable coronary artery disease patients treated with aspirin" @default.
• W2769601183 cites W1414041695 @default.
• W2769601183 cites W1936833235 @default.
• W2769601183 cites W1988143463 @default.
• W2769601183 cites W2012689879 @default.
• W2769601183 cites W2018232825 @default.
• W2769601183 cites W2075740857 @default.
• W2769601183 cites W2108792542 @default.
• W2769601183 cites W2113753184 @default.
• W2769601183 cites W2121790485 @default.
• W2769601183 cites W2126658348 @default.
• W2769601183 cites W2147195562 @default.
• W2769601183 cites W2165632654 @default.
• W2769601183 cites W2170112844 @default.
• W2769601183 cites W2417692855 @default.
• W2769601183 cites W2564427446 @default.
• W2769601183 cites W2568043930 @default.
• W2769601183 doi "https://doi.org/10.1002/ccd.27437" @default.
• W2769601183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29193683" @default.
• W2769601183 hasPublicationYear "2017" @default.
• W2769601183 type Work @default.
• W2769601183 sameAs 2769601183 @default.
• W2769601183 citedByCount "5" @default.
• W2769601183 countsByYear W27696011832018 @default.
• W2769601183 countsByYear W27696011832020 @default.
• W2769601183 countsByYear W27696011832022 @default.
• W2769601183 crossrefType "journal-article" @default.
• W2769601183 hasAuthorship W2769601183A5001000588 @default.
• W2769601183 hasAuthorship W2769601183A5003077195 @default.
• W2769601183 hasAuthorship W2769601183A5007272877 @default.
• W2769601183 hasAuthorship W2769601183A5008382551 @default.
• W2769601183 hasAuthorship W2769601183A5022982945 @default.
• W2769601183 hasAuthorship W2769601183A5025868173 @default.
• W2769601183 hasAuthorship W2769601183A5028243601 @default.
• W2769601183 hasAuthorship W2769601183A5034295349 @default.
• W2769601183 hasAuthorship W2769601183A5040244597 @default.
• W2769601183 hasAuthorship W2769601183A5048484701 @default.
• W2769601183 hasAuthorship W2769601183A5060918182 @default.
• W2769601183 hasAuthorship W2769601183A5069704118 @default.
• W2769601183 hasConcept C126322002 @default.
• W2769601183 hasConcept C141071460 @default.
• W2769601183 hasConcept C164705383 @default.
• W2769601183 hasConcept C179755657 @default.
• W2769601183 hasConcept C188816634 @default.
• W2769601183 hasConcept C2777628954 @default.
• W2769601183 hasConcept C2778213512 @default.
• W2769601183 hasConcept C2780306776 @default.
• W2769601183 hasConcept C500558357 @default.
• W2769601183 hasConcept C50382708 @default.
• W2769601183 hasConcept C71924100 @default.
• W2769601183 hasConcept C72563966 @default.
• W2769601183 hasConcept C77411442 @default.
• W2769601183 hasConceptScore W2769601183C126322002 @default.
• W2769601183 hasConceptScore W2769601183C141071460 @default.
• W2769601183 hasConceptScore W2769601183C164705383 @default.
• W2769601183 hasConceptScore W2769601183C179755657 @default.
• W2769601183 hasConceptScore W2769601183C188816634 @default.
• W2769601183 hasConceptScore W2769601183C2777628954 @default.
• W2769601183 hasConceptScore W2769601183C2778213512 @default.
• W2769601183 hasConceptScore W2769601183C2780306776 @default.
• W2769601183 hasConceptScore W2769601183C500558357 @default.
• W2769601183 hasConceptScore W2769601183C50382708 @default.
• W2769601183 hasConceptScore W2769601183C71924100 @default.
• W2769601183 hasConceptScore W2769601183C72563966 @default.
• W2769601183 hasConceptScore W2769601183C77411442 @default.
• W2769601183 hasFunder F4320309663 @default.
• W2769601183 hasIssue "4" @default.
• W2769601183 hasLocation W27696011831 @default.
• W2769601183 hasLocation W27696011832 @default.
• W2769601183 hasOpenAccess W2769601183 @default.
• W2769601183 hasPrimaryLocation W27696011831 @default.
• W2769601183 hasRelatedWork W2047967234 @default.
• W2769601183 hasRelatedWork W2064286441 @default.
• W2769601183 hasRelatedWork W2195679007 @default.
• W2769601183 hasRelatedWork W2332797319 @default.
• W2769601183 hasRelatedWork W2367140913 @default.
• W2769601183 hasRelatedWork W2417414779 @default.
• W2769601183 hasRelatedWork W2439875401 @default.
• W2769601183 hasRelatedWork W2542248393 @default.
• W2769601183 hasRelatedWork W2790353319 @default.
• W2769601183 hasRelatedWork W2950169628 @default.
• W2769601183 hasVolume "92" @default.

• next